Publication:
Synthesis and standardization of an impurity of acetaminophen, development and validation of liquid chromatographic method

dc.contributor.authorKULABAŞ, NECLA
dc.contributor.authorKÜÇÜKGÜZEL, İLKAY
dc.contributor.authorsArıkan C. C., KULABAŞ N., KÜÇÜKGÜZEL İ.
dc.date.accessioned2023-01-02T11:24:36Z
dc.date.accessioned2026-01-11T18:19:05Z
dc.date.available2023-01-02T11:24:36Z
dc.date.issued2023-01-20
dc.description.abstract© 2022 Elsevier B.V.One of the impurities of acetaminophen, N,N\"-(oxydi-4,1-phenylene)diacetamide (ODAA), which is not specified in the organic impurities analysis method of acetaminophen by high performance liquid chromatography (HPLC) in American Pharmacopoeia Version 42 (USP 42), was synthesized, characterized and standardized. A new and optimized liquid chromatographic method for the determination of organic impurities of acetaminophen was developed using an ultra-high performance liquid chromatographic (UHPLC) system, which can separate this impurity. This new liquid chromatographic method has been optimized and validated for the simultaneous determination of acetaminophen related compound B, acetaminophen related compound C, acetaminophen related compound D, acetaminophen related compound J and ODAA, the organic impurities in acetaminophen drug substance. Acetaminophen was also subjected to stress-testing under acidic hydrolysis, alkaline hydrolysis, oxidative degradation, thermal degradation and photolytic degradation for 15 days. The impurity molecule, ODAA was synthesized using 4,4′-oxydianiline and acetic anhydride. The chemical structure of the synthesized ODAA molecule was confirmed by characterization studies. The potency of ODAA was found to be 99.64% as a result of the relevant analyses. The chromatographic separation was achieved on a C8 (150 mm × 2.1 mm; 2-µm particle size) reversed-phase column using a gradient elution, being solvent A: methanol-water-glacial acetic acid (50:950:1, v/v/v) and solvent B: methanol-water-glacial acetic acid (500:500:1, v/v/v) flowing at a rate of 0.2 mL/min. The limits of quantitation (S/N 10:1) were 1.248 µg/mL for acetaminophen, 0.373 µg/mL for acetaminophen related compound B, 1.217 µg/mL for acetaminophen related compound C, 0.369 µg/mL for acetaminophen related compound D, 0.125 µg/mL for acetaminophen related compound J and 0.373 µg/mL for ODAA. The individual mean recoveries of each impurity molecule spiked into acetaminophen samples at different concentration levels ranged from 93% to 104%. The method developed for UHPLC instrument was successfully applied to the analyses of different lots of acetaminophen. Thus, the proposed method can be used for determination of this impurity in the presence of other specified impurities of acetaminophen.
dc.identifier.citationArıkan C. C., KULABAŞ N., KÜÇÜKGÜZEL İ., "Synthesis and standardization of an impurity of acetaminophen, development and validation of liquid chromatographic method", Journal of Pharmaceutical and Biomedical Analysis, cilt.223, 2023
dc.identifier.doi10.1016/j.jpba.2022.115123
dc.identifier.issn0731-7085
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85140883217&origin=inward
dc.identifier.urihttps://hdl.handle.net/11424/284672
dc.identifier.volume223
dc.language.isoeng
dc.relation.ispartofJournal of Pharmaceutical and Biomedical Analysis
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectTıp
dc.subjectYaşam Bilimleri
dc.subjectMoleküler Biyoloji ve Genetik
dc.subjectSitogenetik
dc.subjectKimya
dc.subjectAnalitik Kimya
dc.subjectFizikokimya
dc.subjectSpektroskopi
dc.subjectSağlık Bilimleri
dc.subjectTemel Bilimler
dc.subjectMedicine
dc.subjectLife Sciences
dc.subjectMolecular Biology and Genetics
dc.subjectCytogenetic
dc.subjectChemistry
dc.subjectAnalytical Chemistry
dc.subjectPhysical Chemistry
dc.subjectSpectroscopy
dc.subjectHealth Sciences
dc.subjectNatural Sciences
dc.subjectKlinik Tıp (MED)
dc.subjectTemel Bilimler (SCI)
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectKlinik Tıp
dc.subjectTROPİKAL TIP
dc.subjectKİMYA, ANALİTİK
dc.subjectSPEKTROSKOPİ
dc.subjectBİYOKİMYA VE MOLEKÜLER BİYOLOJİ
dc.subjectClinical Medicine (MED)
dc.subjectNatural Sciences (SCI)
dc.subjectLife Sciences (LIFE)
dc.subjectCLINICAL MEDICINE
dc.subjectCHEMISTRY
dc.subjectMOLECULAR BIOLOGY & GENETICS
dc.subjectTROPICAL MEDICINE
dc.subjectCHEMISTRY, ANALYTICAL
dc.subjectSPECTROSCOPY
dc.subjectBIOCHEMISTRY & MOLECULAR BIOLOGY
dc.subjectFizik Bilimleri
dc.subjectFarmasötik bilim
dc.subjectİlaç Keşfi
dc.subjectKlinik Biyokimya
dc.subjectPhysical Sciences
dc.subjectPharmaceutical Science
dc.subjectDrug Discovery
dc.subjectClinical Biochemistry
dc.subjectAcetaminophen impurities
dc.subjectN,N'-(oxydi-4,1-phenylene)diacetamide
dc.subjectStandardization
dc.subjectStress-testing
dc.subjectUHPLC
dc.subjectValidation
dc.titleSynthesis and standardization of an impurity of acetaminophen, development and validation of liquid chromatographic method
dc.typearticle
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
file.pdf
Size:
1.93 MB
Format:
Adobe Portable Document Format